Align Technology | ALGN - Current Liabilities


Align Technology reported $1.91B in Current Liabilities for its fiscal quarter ending in September of 2026.





Current Liabilities Change Date
3M USD 11.87B 489M Sep/2026
Align Technology USD 1.91B 4.9M Sep/2026
Becton, Dickinson and Co. USD 9.54B 139M Sep/2026
Bruker USD 1.17B 32.6M Sep/2026
Cardinal Health USD 46.33B 2.42B Sep/2026
Charles River Laboratories USD 1.09B 45.49M Sep/2026
Cooper Companies USD 1.87B 61.9M Jun/2026
CVS Health USD 93.1B 6.06B Sep/2026
Danaher USD 9.05B 945M Sep/2026
Dentsply International USD 1.22B 32M Sep/2026
Dexcom USD 2.25B 105.1M Sep/2026
Henry Schein USD 3.6B 110M Sep/2026
Idexx Laboratories USD 1.26B 23.44M Sep/2026
Insulet USD 814.4M 70.2M Sep/2026
Integra LifeSciences USD 329M 1.88M Sep/2026
IQVIA Holdings USD 7.78B 1.04B Sep/2026
McKesson USD 74.4B 4.04B Sep/2026
Mettler Toledo International USD 1.25B 49.81M Sep/2026
Revvity USD 701.48M 574.88M Sep/2026
Solventum Corp USD 3.58B 88M Sep/2026
Stryker USD 6.5B 184M Sep/2026
Teleflex USD 917.1M 196.72M Sep/2026
Thermo Fisher Scientific USD 14.17B 899M Sep/2026
Veeva Systems USD 1.46B 245.82M Jun/2026
Waters USD 2.4B 126M Jun/2026
Zimmer Biomet Holdings USD 3.5B 488.9M Sep/2026
Zoetis USD 2.68B 621M Sep/2026